Crinetics Pharmaceuticals, Inc.
CRNXCrinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.
Drugs in Pipeline
5
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Aug 4, 2026
4wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How CRNX's past catalysts played out
Paltusotine
Acromegaly
Atumelnant
Congenital Adrenal Hyperplasia
atumelnant (CRN04894)
Congenital Adrenal Hyperplasia
Randomized: 40 mg Paltusotine
Carcinoid Syndrome
CRN09682
SST2-positive Neuroendocrine Neoplasms
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Paltusotine | Phase 3 | Acromegaly | - | - |
Atumelnant | Phase 3 | Congenital Adrenal Hyperplasia | - | - |
atumelnant (CRN04894) | Phase 2 | Congenital Adrenal Hyperplasia | - | - |
Randomized: 40 mg Paltusotine | Phase 2 | Carcinoid Syndrome | - | - |
CRN09682 | Phase 2 | SST2-positive Neuroendocrine Neoplasms | - | - |
Acromegaly
2 drugs in this indication
Congenital Adrenal Hyperplasia
2 drugs in this indication
Carcinoid Syndrome
1 drug in this indication
SST2-positive Neuroendocrine Neoplasms
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Crinetics Pharmaceuticals, Inc.'s drug pipeline?→
CatalystAlert tracks 5 drug candidates in Crinetics Pharmaceuticals, Inc.'s (CRNX) pipeline across Phase 3, Phase 2. Its lead program is Paltusotine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Crinetics Pharmaceuticals, Inc.'s next FDA catalyst?→
Crinetics Pharmaceuticals, Inc.'s (CRNX) next tracked catalyst is a Earnings expected August 4, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track CRNX biotech catalysts?→
Add CRNX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Crinetics Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.